Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1987 Mar;50(3):313–320. doi: 10.1136/jnnp.50.3.313

Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.

A Twijnstra, A P van Zanten, A A Hart, B W Ongerboer de Visser
PMCID: PMC1031796  PMID: 3559613

Abstract

Lactate dehydrogenase (LDH) activities were measured in cerebrospinal fluid in 350 patients with various neurological diseases to establish the sensitivity and specificity of the CSF LDH as a marker for the diagnosis of leptomeningeal metastases. Slight elevations of CSF LDH were observed in nonmalignant diseases, while marked elevations were observed in a considerable number of patients with bacterial meningitis. A sensitivity of 79% and a specificity of 83% were calculated. In the 34 patients with leptomeningeal metastases from solid and haematological tumours, the LDH in lumbar and ventricular CSF were measured simultaneously. The lumbar CSF LDH concentration in patients with leptomeningeal metastases was about five times greater than that in the ventricular CSF. No relationship was found between the CSF LDH and histology of the primary tumour. A good correlation was demonstrated between the lumbar CSF LDH and the effected area of the neuraxis. Serial determinations of CSF LDH showed a relationship between level changes and responses to therapy or progression. The findings of this study indicate that measurement of LDH in CSF can be used as an adjunctive diagnostic test for leptomeningeal metastases and in monitoring the efficacy of treatment.

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaty H. N., Oppenheimer S. Cerebrospinal-fluid lactic dehydrogenase and its isoenzymes in infections of the central nervous system. N Engl J Med. 1968 Nov 28;279(22):1197–1202. doi: 10.1056/NEJM196811282792204. [DOI] [PubMed] [Google Scholar]
  2. Brereton H. D., O'Donnell J. F., Kent C. H., Matthews M., Dunnick N. R., Johnson R. E. Spinal meningeal carcinomatosis in small-cell carcinoma of the lung. Ann Intern Med. 1978 Apr;88(4):517–519. doi: 10.7326/0003-4819-88-4-517. [DOI] [PubMed] [Google Scholar]
  3. Buhl S. N., Jackson K. Y. Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin Chem. 1978 May;24(5):828–831. [PubMed] [Google Scholar]
  4. Davies-Jones G. A. Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in tumours of the central nervous system. J Neurol Neurosurg Psychiatry. 1969 Aug;32(4):324–327. doi: 10.1136/jnnp.32.4.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dharker S. R., Dharker R. S., Chaurasia B. D. Lactate dehydrogenase and aspartete transaminase of the cerebrospinal fluid in patients with brain tumours, congenital hydrocephalus, and brain abscess. J Neurol Neurosurg Psychiatry. 1976 Nov;39(11):1081–1085. doi: 10.1136/jnnp.39.11.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FLEISHER G. A., WAKIM K. G., GOLDSTEIN N. P. Glutamic-oxalacetic transaminase and lactic dehydrogenase in serum and cerebrospinal fluid of patients with neurologic disorders. Proc Staff Meet Mayo Clin. 1957 Apr 17;32(8):188–197. [PubMed] [Google Scholar]
  7. GOLDMAN R. D., KAPLAN N. O., HALL T. C. LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES. Cancer Res. 1964 Apr;24:389–399. [PubMed] [Google Scholar]
  8. GREEN J. B., OLDEWURTEL H. A., O'DOHERTY D. S., FORSTER F. M. Cerebrospinal fluid transaminase and lactic dehydrogenase activities in neurologic disease. AMA Arch Neurol Psychiatry. 1958 Aug;80(2):148–156. doi: 10.1001/archneurpsyc.1958.02340080018002. [DOI] [PubMed] [Google Scholar]
  9. Gay R. J., McComb R. B., Bowers G. N., Jr Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. Clin Chem. 1968 Aug;14(8):740–753. [PubMed] [Google Scholar]
  10. Glass J. P., Melamed M., Chernik N. L., Posner J. B. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979 Oct;29(10):1369–1375. doi: 10.1212/wnl.29.10.1369. [DOI] [PubMed] [Google Scholar]
  11. Greenberg H. S., Deck M. D., Vikram B., Chu F. C., Posner J. B. Metastasis to the base of the skull: clinical findings in 43 patients. Neurology. 1981 May;31(5):530–537. doi: 10.1212/wnl.31.5.530. [DOI] [PubMed] [Google Scholar]
  12. HAIN R. F., NUTTER J. Cerebrospinal fluid enzymes as a function of age: its effect upon the significance of elevated values in various diseases of the nervous system. Arch Neurol. 1960 Mar;2:331–337. doi: 10.1001/archneur.1960.03840090095011. [DOI] [PubMed] [Google Scholar]
  13. Hirsch F. R., Paulson O. B., Hansen H. H., Vraa-Jensen J. Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer. 1982 Dec 1;50(11):2433–2437. doi: 10.1002/1097-0142(19821201)50:11<2433::aid-cncr2820501131>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  14. JAKOBY R. K., JAKOBY W. B. Lactic dehydrogenase of cerebrospinal fluid in the differential diagnosis of cerebrovascular disease and brain tumor. J Neurosurg. 1958 Jan;15(1):45–51. doi: 10.3171/jns.1958.15.1.0045. [DOI] [PubMed] [Google Scholar]
  15. Koch T. R., Lichtenfeld K. M., Wiernik P. H. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin. Cancer. 1983 Jul 1;52(1):101–104. doi: 10.1002/1097-0142(19830701)52:1<101::aid-cncr2820520119>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  16. Loewenstein M. S., Rittgers R. A., Feinerman A. E., Kupchik H. Z., Marcel B. R., Koff R. S., Zamcheck N. Carcinoembryonic antigen assay of ascites and detection of malignancy. Ann Intern Med. 1978 May;88(5):635–638. doi: 10.7326/0003-4819-88-5-635. [DOI] [PubMed] [Google Scholar]
  17. Marton L. J., Heby O., Wilson C. B. Increased polyamine concentrations in the cerebrospinal fluid of patients with brain tumors. Int J Cancer. 1974 Dec 15;14(6):731–735. doi: 10.1002/ijc.2910140606. [DOI] [PubMed] [Google Scholar]
  18. Morganroth J., Deisseroth A., Winokur S., Schein P. Differentiation of carcinomatous and bacterial meningitis. Neurology. 1972 Dec;22(12):1240–1242. doi: 10.1212/wnl.22.12.1240. [DOI] [PubMed] [Google Scholar]
  19. Naus A. J., Borst A., Kuppens P. S. The use of patient data for the calculation of reference values for some haematological parameters. J Clin Chem Clin Biochem. 1980 Oct;18(10):621–625. doi: 10.1515/cclm.1980.18.10.621. [DOI] [PubMed] [Google Scholar]
  20. Nelson P. V., Carey W. F., Pollard A. C. Diagnostic significance and source of lactate dehydrogenase and its isoenzymes in cerebrospinal fluid of children with a variety of neurological disorders. J Clin Pathol. 1975 Oct;28(10):828–833. doi: 10.1136/jcp.28.10.828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nugent J. L., Bunn P. A., Jr, Matthews M. J., Ihde D. C., Cohen M. H., Gazdar A., Minna J. D. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer. 1979 Nov;44(5):1885–1893. doi: 10.1002/1097-0142(197911)44:5<1885::aid-cncr2820440550>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  22. Olson M. E., Chernik N. L., Posner J. B. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol. 1974 Feb;30(2):122–137. doi: 10.1001/archneur.1974.00490320010002. [DOI] [PubMed] [Google Scholar]
  23. Ongerboer de Visser B. W., Somers R., Nooyen W. H., van Heerde P., Hart A. A., McVie J. G. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology. 1983 Dec;33(12):1565–1572. doi: 10.1212/wnl.33.12.1565. [DOI] [PubMed] [Google Scholar]
  24. Persijn J. P., Korsten C. B., Batterman J. J., Tierie A. H., Renaud J. Clinical significance of urinary carcino-embryonic antigen estimations during the follow-up of patients with bladder carcinoma or previous bladder carcinoma. Clinical evaluation of carcino-embryonic antigen, III. J Clin Chem Clin Biochem. 1976 Aug;14(8):395–399. doi: 10.1515/cclm.1976.14.1-12.395. [DOI] [PubMed] [Google Scholar]
  25. Rabow L., Kristensson K. Changes in lactate dehydrogenase isoenzyme patterns in patients with tumours of the central nervous system.? Acta Neurochir (Wien) 1977;36(1-2):71–81. doi: 10.1007/BF01405988. [DOI] [PubMed] [Google Scholar]
  26. Rosen S. T., Aisner J., Makuch R. W., Matthews M. J., Ihde D. C., Whitacre M., Glatstein E. J., Wiernik P. H., Lichter A. S., Bunn P. A., Jr Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore) 1982 Jan;61(1):45–53. doi: 10.1097/00005792-198201000-00005. [DOI] [PubMed] [Google Scholar]
  27. SPOLTER H., THOMPSON H. G., Jr Factors affecting lactic dehydrogenase and glutamic oxalacetic transaminase activities in cerebrospinal fluid. Neurology. 1962 Jan;12:53–59. doi: 10.1212/wnl.12.1.53. [DOI] [PubMed] [Google Scholar]
  28. Sayk J., Olischer R. M. Fortschritte der Liquorzytologie bei der Diagnostik bösartiger Hirngeschwülste (3. Mitteilung) Psychiatr Neurol Med Psychol (Leipz) 1967 Mar;19(3):88–99. [PubMed] [Google Scholar]
  29. Schold S. C., Wasserstrom W. R., Fleisher M., Schwartz M. K., Posner J. B. Cerebrospinal fluid biochemical markers of central nervous system metastases. Ann Neurol. 1980 Dec;8(6):597–604. doi: 10.1002/ana.410080609. [DOI] [PubMed] [Google Scholar]
  30. Sharpe D. M., Wilcock A. R., Goldberg D. M. Automated kinetic spectrophotometric assays of enzyme activities of human cerebrospinal fluid: methods and reference values. Clin Chem. 1973 Feb;19(2):240–247. [PubMed] [Google Scholar]
  31. Shuttleworth E., Allen N. CSF beta-glucuronidase assay in the diagnosis of neoplastic meningitis. Arch Neurol. 1980 Nov;37(11):684–687. doi: 10.1001/archneur.1980.00500600032003. [DOI] [PubMed] [Google Scholar]
  32. WROBLEWSKI F., DECKER B., WROBLEWSKI R. Activity of lactic dehydrogenase in spinal fluid. Am J Clin Pathol. 1957 Sep;28(3):269–271. doi: 10.1093/ajcp/28.3.269. [DOI] [PubMed] [Google Scholar]
  33. WROBLEWSKI F., DECKER B., WROBLEWSKI R. The clinical implications of spinal-fluid lactic dehydrogenase activity. N Engl J Med. 1958 Mar 27;258(13):635–639. doi: 10.1056/NEJM195803272581303. [DOI] [PubMed] [Google Scholar]
  34. van Zanten A. P., Twijnstra A., van Benthem V., Hart A. A., Ongerboer de Visser B. W. Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases. Clin Chim Acta. 1985 Apr 15;147(2):127–134. doi: 10.1016/0009-8981(85)90073-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES